INTRODUCTION
Mammalian ribonucleotide reductase is responsible for the de novo conversion of ribonucleotides into the four deoxyribonucleotides required for the synthesis of DNA, and therefore plays a critical role in cell division and cell proliferation [1, 2] . The enzyme consists of two dissimilar protein components often called RI and R2. RI is a dimer with an Mr of 170000 and contains binding sites for substrates and allosteric effectors, whereas R2 is a dimer with an Mr ifi 000 and contains iron and a tyrosyl free radical that is essential for ribonucleotide reduction [1, 3] . Enzyme activity requires both components, but different mechanisms regulate RI and R2 during cell proliferation [1] , and changes in enzyme activity and in RI and/or R2 gene expression have been observed under a variety of environmental conditions [1] [2] [3] [4] [5] [6] . The importance of ribonucleotide reductase for cell proliferation is further emphasized by observations that the mechanisms controlling ribonucleotide reductase gene expression may be altered in some malignant conditions [2] [3] [4] [5] [6] [7] , and are involved in the early events underlying the action of the tumour promoter phorbol 12-myristate 13-acetate (PMA; 'TPA') [1] . For example, we have recently shown that treatment of mouse 3T3 fibroblasts with PMA significantly increases the steady-state level and the stability of the RI subunit mRNA [8] . Furthermore, we have proposed a model of RI gene regulation in which a ciselement within a 49-nt sequence of the 3'-untranslated region (3'UTR) of the RI message interacts with a cytoplasmic protein (RIBP) in a mechanism that regulates RI message stability and is responsive to PMA treatment [8] .
as PMA and okadaic acid increased the stability of these messages, in a dose-dependent manner. In contrast, treatment of cells with forskolin, a protein kinase A inhibitor, did not alter either RIBP-RNA binding or RI mRNA-stability characteristics. Transfectants containing RI or CAT/RI cDNA constructs with a deletion of the 49-nt 3'UTR sequence failed to respond in message-stability studies to the effects of PMA, staurosporine or okadaic acid. These observations indicate that a protein kinase C signal pathway regulates ribonucleotide reductase RI gene expression post-transcriptionally, through a mechanism involving a specific cis-trans interaction at a 49-nt region within the RI mRNA 3'UTR.
Although important details concerning the mode of action of PMA are still unknown, many of its diverse effects (see, e.g., [9] [10] [11] ) appear to be mediated through the regulation of protein kinase C (PKC), a high-affinity receptor for PMA [12, 13] . Also, it has been demonstrated that PMA can modulate the transcription of such important growth-controlling genes as c-myc [14, 15] , c-fos [15] and c-sis [16] , through cis-trans interactions between responsive DNA elements and binding proteins. The activity of the trans-acting proteins (e.g. AP-1 and AP-2) can be regulated through the action of PKC in response to PMA treatment [17, 18] . Although it is now clear from several recent studies that cis-trans interactions are also involved in posttranscriptional regulation of gene expression [19, 20] , relatively little is known about the signal pathway(s) that control PMAmediated alterations in gene expression through direct modifications in the cis-trans reactions that regulate message-stability properties [8, 21] . The present study was undertaken to provide information on this topic. In vitro transcription of the plasmid constructs was performed using an SP6/T7 transcription kit (Boehringer, Mannheim) to produce transcripts by SP6 polymerase from 0.5 /ag of plasmid construct DNA as described previously [8] . Briefly, mRNA was transcribed using SP6 RNA polymerase at 37°C for 1 h in the presence of [32P]CTP (3000 Ci/nmol; Amersham International), nucleotides, RNasin and buffer conditions as described by the manufacturer. After transcription, template DNA was digested with DNAase I. After extraction and precipitation, RNA transcripts were purified by electrophoresis through a 40% native polyacrylamide gel, eluted, precipitated with ethanol, and reconstituted in diethyl pyrocarbonate-treated water.
Analysis of protein-RNA Interactions
Binding reactions were performed to detect protein-RNA complex formation using 20 jig of cytoplasmic protein prepared as described by Malter [23] , incubated with 1.5 x 104 c.p.m. of 32P_ labelled transcript at 30°C for 30 min in a final volume of 10 ltl.
Unprotected probe was digested by incubation with 50 units of RNAase T1 (BRL) for 30 min. To exclude non-specific protein binding, heparin (5 mg/ml) was added, and the mixture was incubated at room temperature for an additional 10 min.
RNA-protein complexes were analysed with 70% native polyacrylamide gels.
For u.v. cross-linking of RNA and protein, the reaction mixtures were put on ice immediately after the addition of heparin and irradiated by u.v. light at 2500 ,J for 15 min, using a UV-Stratalinker chamber apparatus (Stratagene). The samples were then resolved by electrophoresis with a 7 %-SDS/ polyacrylamide gel under reducing conditions [8] . Protein concentrations were determined by the Bio-Rad protein assay kit (Bio-Rad) according to the manufacturer's instructions.
Plasmid construction and cell transfections
The cloned RI cDNA [24] contains 242 bp of 5'UTR, 2379 bp of coding region and 443 bp of 3'UTR. A fragment containing the entire mouse RI cDNA was derived from the plasmid pCD-R1 [24] with XhoI digestion. pRlmc (construct a of Figure lb ) was generated by inserting this XhoI-digested fragment into a Sall site in the polylinker of the pECE expression vector [25] in the sense orientation under control of a simian-virus-40 promoter. The RI cDNA 3'UTR deletion construct, pR13D2 (construct b of Figure lb) , was made by digestion of pRlmc with XbaI to remove a XbaI/XbaI fragment containing a downstream 49 bp sequence in the RI 3'UTR, followed by ligation using T4 DNA ligase (BRL).
For the preparation of CAT/RI hybrid constructs, a Hindllll BanI fragment containing part of the CAT 5'UTR and the full sequence (715 bp) of the coding region was removed from the pSVIacOCAT plasmid [26] , and inserted into the BglII site in the polylinker of the pECE plasmid. The full-length RI cDNA sequence was then inserted into the polylinker at the Sall site, and a fragment containing the 5'UTR and coding region of RI cDNA was deleted with HindlIl and Drall to generate the construct pCAT-R13 (construct c of Figure Ib) . The Ri 3'UTR of CAT-R13 was located downstream of the CAT-coding region. pCAT-R132 (construct d of Figure lb) was prepared by digesting pCAT-R13 with XbaI to remove the 49 bp fragment at the 3'end of RI cDNA, followed by re-ligation [27] .
Transfection of COS 7 cells was carried out by the calcium phosphate method described previously [28, 29] . Briefly, plasmid DNA constructs were co-transfected with selectable marker plasmid, pSV2neo [30] , at a 30 :1 ratio. Stably transfected COS 7 cells were selected with 400 ,g of G418 (Gibco Laboratories)/ml of medium, starting 48 h after addition of the plasmid/calcium phosphate precipitate to the cells. After about 4 weeks of culture, colonies were pooled and expanded. Northern-blot analysis [3] [4] [5] [6] 8] and CAT assays [8, 31] were performed to screen for stable transfectants.
RNA isolation and Northern-blot analysis Total RNA was extracted from proliferating cells by the method described by Gough [32] . Transcription was inhibited by addition of 10 ,ug of actinomycin D/ml of medium [8, 20] . A 20,ug portion of total cellular RNA was electrophoresed through 1 %0
formaldehyde/agarose gels, followed by transfer to Zeta-probe nitrocellulose membranes (Bio-Rad). RNA blots were prehybridizedfor5in for 5 mm nd probedfor 1624h in formamide hybridization solution containing (1-2) x 106 c.p.m./ml of a32p_ A protein kinase C signal pathway Is involved In the regulation of
R1BP-RNA binding actvity
Since PMA is a potent PKC stimulator [12, 13] , and we have shown previously that PMA treatment decreases the binding between RIBP and the 49-nt 3'UTR sequence [8] , we tested the hypothesis that a phosphorylation pathway is critically involved in mediating the PMA effects observed on RIBP-RNA binding activity (Figure 2 ). Full-length RI transcripts and cytosolic extracts from pRlmc-transfected COS 7 cells (Figure lb , construct a), were used in gel mobility assays. Cells were treated for various times with staurosporine (a PKC inhibitor), okadaic acid (an inhibitor of phosphoserine/phosphothreonine protein phosphatases 1 and 2A) or forskolin (a stimulator of protein kinase A activity) [5, 33] . Transcription was blocked by treatment with actinomycin D [8, 20] . Control experiments included the treatment of cells with DMSO, which had no effect on protein-RNA binding activity in u.v.-cross-linking experiments, or with PMA, which dramatically decreased the binding activity (Figure 3a ), in agreement with previous studies [8] . Interestingly, the crosslinking experiments showed that staurosporine treatment for only 30 min markedly increased protein-RNA binding activity (Figure 3a) . These results suggest that a direct relationship exists between PKC activity and the interaction of RIBP with RI mRNA. Similar to the effects of PMA on protein-RNA binding activity, treatment of cells with okadaic acid for only 30 min also significantly reduced RI BP-RNA binding (Figure 3a) . Therefore, both stimulation ofPKC by PMA and inhibition ofphosphatases by okadaic acid have similar effects at the level of protein-RI mRNA binding activity. These PKC-related effects appear to be specific, since treatment with forskolin, a stimulator of the PKA signal pathway, did not alter RlBP-RNA binding activity (Figure 3a (Figure 3b ). As expected from earlier u.v.-cross-linking results (Figure 3a ) and message-stability experiments (Figure 4) , concentrations of forskolin as high as 50 ,uM did not affect RI BP binding to RI mRNA (Figure 3b) . As an estimate of messagestability characteristics following transcription inhibition with actinomycin D [8, 20] , COS 7 cells transfected with either pRImc or pCAT-R13 were treated with various concentrations of the phosphorylation-modifying compounds for several hours and the levels of RI message (Figure 4a ) or CAT/RI message ( Figure  4b ) were determined by Northern-blot analysis [8, 34] . Dosedependent effects on message-stability properties were observed with PMA, staurosporine and okadaic acid treatments. In keeping with earlier observations (Figure 3b) , treatment with a variety of forskolin concentrations did not appear to alter the stability characteristics of RI mRNA (Figure 4a ). Indeed, attempts to modify the message-stability properties of RI by exposing cells directly to cyclic AMP in the form of a biologically stable analogue (8-bromo cyclic AMP) as high as 0.8 mM also had no effect (results not shown).
Modulation of RlBP-RNA binding activity by staurosporine and okadaic acid affects RI and CAT/Ri mRNA stability COS 7 cells were transfected with pRImc and pCAT-RI3 constructs (Figure 1 b, constructs a and c) , treated with actinomycin D to block transcription [8, 20] , and exposed to PMA, staurosporine, okadaic acid or forskolin. Northern-blot analyses were performed to determine the half-lives of R1 message ( Figure  5 CAT/RI message stability by approx. 3.2-and 2.5-fold respectively. Similar to the observations made with okadaic acid, PMA treatment increased the half-lives of RI and CAT/RI mRNA turnover rates by 3.7-and 2.6-fold respectively. Interestingly, an inverse relationship between the effects of staurosporine, okadaic acid and PMA on message stability ( Figure 5 ) and RlBP-RI mRNA binding activity (Figure 3a) was observed. Also, as expected from the u.v.-cross-linking results (Figure 3a) , treatment of cells with forskolin did not have a significant effect on RI message half-life. These observations are consistent with the notion that the PKC signal pathway is intimately linked to RI message stability through a mechanism that directly regulates protein-mRNA binding activity.
The R1BP-49 nt interaction is necessary for staurosporine and okadaic acid Rl message-stability regulation
To study the role of RlBP-49 nt interactions in the regulation of RI mRNA turnover, COS 7 cells transfected with the 49-nt 3'UTR deletion constructs, pRI 3D2 and pCAT-Rl 32 ( Figure Ib , constructs b and d), were blocked at transcription, treated with the phosphorylation-modifying compounds staurosporine, okadaic acid or forskolin, and message half-lives were determined by Northern-blot analysis [8, 34] . In contrast with studies carried out with RI and CAT/RI message constructs containing the 49-nt 3'UTR, no significant effects on the stabilities of RI or CAT/RI messages lacking the 49-nt sequence were detected after treatment with these compounds (Figure 6 ). These observations indicate the importance of the 49-nt region in the RI Figure) with phosphorylation-modifying agents, at the concentrations described in the Materials and methods section. Northern-blot analysis of the mRNA half-lives were carried out after the extraction of total RNA. A GAPDH cDNA was used to determine loading, and a representive result is provided at the bottom of (a) and (b). The half-lives of R13D2 (0.5 h) and CAT-Ri 32 (1.5 h), detected after treatment with DMSO (control), were not significantly altered after treatment with the various compounds. 
DISCUSSION
PMA is a potent biological response modulator with a diverse range of effects on cells, in vivo and in cell culture [9] [10] [11] . Many of the pleiotropic effects of PMA and related tumour promoters occur at the cell membrane. Studies have shown that the membrane-associated receptor for PMA is the multifunctional serine/threonine-specific protein kinase PKC, which is regulated by intracellular levels of free Ca2+ and 1,2-diacylglycerol (DAG) [35, 36] . PMA appears to act as a DAG analogue and induces a direct activation of PKC in intact cells [37] . Indeed, the variety of responses elicited by PMA-induced PKC activation appears, in part, to be due to the existence of a PKC gene family [38] [39] [40] .
There are two general ways in which PMA, through a PKC pathway, may modify gene expression. One involves transcription, where cis-trans interactions at the DNA level is regulated by PKC in response to PMA treatment [17, 18] . At the posttranscriptional level several studies have demonstrated changes in message-stability characteristics after exposure to PMA (see, e.g., [8, 21] ). The present study connects, for the first time, the action of the tumour promoters PMA and okadaic acid [41, 42] and the PKC signal pathway to a post-transcriptional mechanism of message stability mediated by a specific cis-trans reaction at the 3'UTR of Rl mRNA. We also show that this tumour promoter responsive reaction involves a protein of approx. 57000, RIBP, and a sequence within a 49-nt region of the RI 3'UTR. Furthermore, the PKC signal pathway appears to be specifically involved in this regulation, since forskolin, a PKA pathway effector, did not alter RI message-stability properties, or the RlBP-Rl mRNA interaction. In keeping with these findings, we have also observed that treatment of cells with 8-bromo cyclic AMP, like forskolin treatment, had no effect on RI message stability, whereas treatment of cells with bisindolylmaleimide GF 109203X, another inhibitor of PKC activity [43] , leads to increased RlBP-Rl mRNA binding activity and decreased RI message stability (results not shown).
The effects of staurosporine and okadaic acid on message stability and on RlBP-RNA binding activity are in agreement with observations obtained with PMA [8] . These results support a general model in which dissociation of RIBP from the RI mRNA 3'UTR is linked to an increase in the stability of RI message, whereas increasing the binding activity leads to mRNA destabilization. The exact role of the RlBP-mRNA complex in the regulation of RI mRNA stability is not yet clear. However, RIBP may be acting as a targeting protein for RI mRNA degradation, or it may be part of a ribonuclease complex directly participating in message turnover. It is also important to note that other regions besides the 49-nt sequence within the RI 3'UTR may also have a role to play in message stability. This is suggested by our observation that RI and CAT/RI messages containing deletions of the 49-nt sequence exhibited shorter halflives ( Figure 6 ) relative to messages containing the full RI 3'UTR ( Figure 5 ). This possibility is not surprising, and is supported by other studies, where, for example, in addition to the repeated AUUUA pentameter in the c-myc mRNA 3'UTR, a second sequence (in the coding region) is also involved in message turnover.
Interestingly, the effects of PMA, staurosporine and okadaic acid on message stability and RIBP-RNA binding activity in monkey and mouse cells are similar, suggesting that the PKC regulation pathway for RI message stability described in the present study is common to these two species and may be conserved in mammals.
In conclusion, the present results indicate that a protein kinase C pathway is linked to the post-transcriptional regulation of ribonucleotide reductase RI gene expression by a mechanism involving an RIBP-mRNA 3'UTR cis-trans interaction.
